Next Article in Journal
Amorphous InGaMgO Ultraviolet Photo-TFT with Ultrahigh Photosensitivity and Extremely Large Responsivity
Next Article in Special Issue
Advances in the Fabrication of Antimicrobial Hydrogels for Biomedical Applications
Previous Article in Journal
Improved Formula for the Stress Intensity Factor of Semi-Elliptical Surface Cracks in Welded Joints under Bending Stress
Previous Article in Special Issue
Synthesis and Drug Delivery Application of Thermo- and pH-Sensitive Hydrogels: Poly(β-CD-co-N-Isopropylacrylamide-co-IAM)
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessReview
Materials 2017, 10(2), 170;

Boronic Acid as Glucose-Sensitive Agent Regulates Drug Delivery for Diabetes Treatment

Laboratory of Building Energy-Saving Technology Engineering, College of Material Science and Engineering, Jilin Jianzhu University, Changchun 130118, China
Department of Endocrinology, China-Japan Union Hospital of Jilin University, Changchun 130033, China
Department of Endocrine, the First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130117, China
Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China
Author to whom correspondence should be addressed.
Academic Editor: Jie Zheng
Received: 4 December 2016 / Revised: 18 January 2017 / Accepted: 6 February 2017 / Published: 13 February 2017
(This article belongs to the Special Issue Smart Biomaterials and Biointerfaces)
Full-Text   |   PDF [3578 KB, uploaded 13 February 2017]   |  


In recent years, glucose-sensitive drug delivery systems have attracted considerable attention in the treatment of diabetes. These systems can regulate payload release by the changes of blood glucose levels continuously and automatically with potential application in self-regulated drug delivery. Boronic acid (BA), especially phenylboronic acid (PBA), as glucose-sensitive agent has been the focus of research in the design of glucose-sensitive platforms. This article reviews the previous attempts at the developments of PBA-based glucose-sensitive drug delivery systems regarding the PBA-functionalized materials and glucose-triggered drug delivery. The obstacles and potential developments of glucose-sensitive drug delivery systems based on PBA for diabetes treatment in the future are also described. The PBA-functionalized platforms that regulate drug delivery induced by glucose are expected to contribute significantly to the design and development of advanced intelligent self-regulated drug delivery systems for treatment of diabetes. View Full-Text
Keywords: phenylboronic acid; glucose-sensitivity; drug delivery; diabetes therapy phenylboronic acid; glucose-sensitivity; drug delivery; diabetes therapy

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Zhao, L.; Huang, Q.; Liu, Y.; Wang, Q.; Wang, L.; Xiao, S.; Bi, F.; Ding, J. Boronic Acid as Glucose-Sensitive Agent Regulates Drug Delivery for Diabetes Treatment. Materials 2017, 10, 170.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Materials EISSN 1996-1944 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top